colchicine has been researched along with Cancer of Prostate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, S; Chen, J; Dalton, JT; Li, W; Lu, Y; Miller, DD; Wang, J | 1 |
| Arnst, KE; Banerjee, S; Deng, S; Kumar, G; Li, GB; Li, W; Miller, DD; Wang, Y; White, SW; Yang, J; Yang, L | 1 |
| Arnst, KE; Chen, H; Kumar, G; Li, W; Ma, D; Miller, DD; Wang, Q; Wang, Y; White, SW; Wu, Z; Yang, J | 1 |
| Fu, DJ; Li, J; Liu, SM; Yang, JJ | 1 |
| Bakar-Ates, F; Ergul, M | 1 |
| Mizugishi, K; Takaori-Kondo, A; Yamashita, K | 1 |
| Blackburn, J; Bondarenko, SP; Chen, J; Deaciuc, A; Dwoskin, LP; Frasinyuk, MS; Hausman, E; Kondratyuk, KM; Kril, LM; Liu, C; Liu, X; Martin, ZM; Sviripa, VM; Watt, DS; Wyrebek, PP; Xie, Y; Yu, T; Zhan, CG; Zhang, W; Zhu, H | 1 |
| Ehteda, A; Galettis, P; Morris, DL; Pillai, K | 1 |
| Chaplin, DJ; Garner, CM; Ghatak, A; Hadimani, MB; Hall, JJ; Hamel, E; Kessler, RJ; Liu, L; Lopez, R; Macdonough, MT; Mason, RP; Nguyen, BL; Pettit, GR; Pinney, KG; Shirali, AR; Sriram, M; Strecker, TE; Trawick, ML | 1 |
| Andaya, C; Arora, S; Keenan, SM; Peng, Y; Wang, XI; Welsh, WJ; Zhang, Q | 1 |
| Calvo, A; Catena, R; Diaz, R; Diaz-Gonzalez, JA; Gonzalez-Moreno, O; Hamel, E; Nguewa, PA; Redrado, M; Serrano, D; Sherris, D | 1 |
| Roef, MJ; van der Laken, CJ; van der Poel, H; Vogel, WV | 1 |
| GRIEM, ML; MALKINSON, FD | 1 |
| Liu, HY; Lü, ZY; Pan, XD; Wang, B; Yang, J; Zhao, JH | 1 |
| Fakih, M; Lehr, JE; Pienta, KJ; Replogle, T; Yagoda, A | 1 |
| Dahllöf, B; Hartley-Asp, B; Laing, N; Ranganathan, S; Tew, KD | 1 |
| Dexter, DW; Hudes, GR; McCauley, RA; Ranganathan, S | 1 |
| McAlpine, RJ | 1 |
18 other study(ies) available for colchicine and Cancer of Prostate
| Article | Year |
|---|---|
Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Imidazoles; Male; Melanoma; Models, Molecular; Paclitaxel; Prostatic Neoplasms; Structure-Activity Relationship; Tubulin Modulators | 2012 |
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy.
Topics: Animals; Apoptosis; Binding Sites; Colchicine; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple; Heterografts; Humans; Male; Melanoma; Polymerization; Prostatic Neoplasms; Pyrimidines; Tubulin | 2018 |
Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities.
Topics: Animals; Cell Proliferation; Chalcones; Humans; Male; Melanoma; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Prostatic Neoplasms; Protein Conformation; Tubulin; Tubulin Modulators; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells.
Topics: Apoptosis; Binding Sites; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Cell Proliferation; Colchicine; Epithelial-Mesenchymal Transition; Humans; Male; Mass Spectrometry; Piperidines; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy | 2020 |
Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Colchicine; DNA Damage; Humans; Male; Matrix Metalloproteinase 9; Membrane Potential, Mitochondrial; Oxidative Stress; PC-3 Cells; Prostatic Neoplasms | 2021 |
Familial Mediterranean Fever Mutations in a Patient with Periodic Episodes of Systemic Pain Deriving from Cancer Bone Metastases.
Topics: Bone Neoplasms; Cancer Pain; Colchicine; Familial Mediterranean Fever; Gout Suppressants; Humans; Male; Middle Aged; Mutation; Prostatic Neoplasms; Pyrin | 2018 |
Semisynthetic aurones inhibit tubulin polymerization at the colchicine-binding site and repress PC-3 tumor xenografts in nude mice and myc-induced T-ALL in zebrafish.
Topics: Animals; Benzofurans; Binding Sites; Colchicine; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; PC-3 Cells; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Protein Multimerization; Tubulin; Xenograft Model Antitumor Assays; Zebrafish | 2019 |
Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice.
Topics: 2-Methoxyestradiol; Albendazole; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colchicine; Colorectal Neoplasms; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; HCT116 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Tubulin Modulators | 2013 |
Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Colchicine; Drug Screening Assays, Antitumor; Humans; Indoles; Inhibitory Concentration 50; Male; Mice; Molecular Structure; Organophosphates; Prodrugs; Prostatic Neoplasms; Stilbenes; Structure-Activity Relationship; Tubulin | 2013 |
Novel microtubule polymerization inhibitor with potent antiproliferative and antitumor activity.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Division; Cell Line; Cell Proliferation; Cell Survival; Colchicine; Colorectal Neoplasms; G2 Phase; Humans; Male; Mice; Microtubules; Prostatic Neoplasms; Tubulin Modulators; Xenograft Model Antitumor Assays | 2009 |
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer.
Topics: bcl-2-Associated X Protein; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Colchicine; Endothelial Cells; Humans; Inhibitor of Differentiation Protein 1; Male; Matrix Metalloproteinase Inhibitors; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Radiation-Sensitizing Agents; Tubulin; Vascular Endothelial Growth Factor A | 2009 |
Colchicine must be stopped before imaging with [18F]-methylcholine PET/CT.
Topics: Aged; Choline; Colchicine; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2010 |
MODIFICATION OF RADIATION RESPONSE OF TISSUE BY COLCHICINE PRELIMINARY CLINICAL EVALUATION.
Topics: Adenocarcinoma; Brachial Plexus; Carcinoma; Carcinoma, Squamous Cell; Colchicine; Colonic Neoplasms; Esophageal Neoplasms; Fibrosarcoma; Gallbladder Neoplasms; Humans; Lung Neoplasms; Male; Mycosis Fungoides; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thyroid Neoplasms; Tongue Neoplasms; Toxicology; Urinary Bladder Neoplasms | 1964 |
Synthesis and antitumor activity of nitrogen-based thiocolchicine derivatives.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Colchicine; Humans; Inhibitory Concentration 50; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred ICR; Models, Chemical; Molecular Structure; Neoplasm Transplantation; Prostatic Neoplasms; Structure-Activity Relationship | 2006 |
Inhibition of prostate cancer growth by estramustine and colchicine.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colchicine; Dose-Response Relationship, Drug; Estramustine; Humans; Male; Prostatic Neoplasms; Tumor Cells, Cultured | 1995 |
Interaction of estramustine with tubulin isotypes.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Binding Sites; Brain; Cattle; Colchicine; Estramustine; Guanosine Diphosphate; Guanosine Triphosphate; Humans; In Vitro Techniques; Male; Microtubule Proteins; Mitosis; Paclitaxel; Prostatic Neoplasms; Tubulin; Vinca Alkaloids | 1997 |
Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
Topics: Antineoplastic Agents; Colchicine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estramustine; Genetic Vectors; Humans; Male; Microtubules; Neoplasm Proteins; Paclitaxel; Prostatic Neoplasms; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tubulin; Tumor Cells, Cultured; Vinblastine | 2001 |
Possible modification of metastasis from adenocarcinoma of the prostate by colchicine: a case report.
Topics: Adenocarcinoma; Arthritis, Gouty; Colchicine; Genes, ras; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prostatic Neoplasms | 1991 |